FDA Adverse Event Injury Summary report: N

CLAREON PANOPTIX TRIFOCAL UV ABSORBING INTRAOCULAR LENS

MDR report key: 24222569 · Received January 30, 2026

Report

Report Number
1119421-2026-00203
Event Type
Injury
Date Received
January 30, 2026
Report Date
April 11, 2026
Manufacturer
ALCON RESEARCH, LLC - HUNTINGTON
Product Code
MFK
UDI-DI
00380652413664
PMA / PMN Number
P190018
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

A PRODUCT WAS NOT RETURNED FOR ANALYSIS. COMPLAINT HISTORY AND PRODUCT HISTORY RECORDS WERE REVIEWED AND DOCUMENTATION INDICATED THE PRODUCT MET RELEASE CRITERIA. ROOT CAUSE HAS NOT BEEN IDENTIFIED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 0

CORRECTION INFORMATION WAS PROVIDED IN H.6. FDA PATIENT CODES (E0839) HAS BEEN REMOVED. FDA PATIENT CODES (E083803) HAS BEEN ADDED. FDA METHOD CODES (B20) HAS BEEN ADDED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A CONSUMER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, PATIENT EXPERIENCED FLUTTER IN THE CORNER OF EYE WITH SUDDEN MOVEMENTS, EPISODES OF CLOUDY VISION, WHICH PHYSICIAN ATTRIBUTED TO FLOATERS. THE PATIENT ALSO NOTED HALOS AT NIGHT WHILE DRIVING, ESPECIALLY WITH ONCOMING HEADLIGHTS. THESE HALOS ARE LESS SEVERE COMPARED TO PRE-SURGERY BUT REMAIN BOTHERSOME. ADDITIONAL INFORMATION WAS RECEIVED PATIENT WAS HAPPY WITH THE VISION, FLUTTERING IS STILL PRESENT. PATIENT WAS SEEKING TO CONTACT HIS SURGEON TO PROVIDE DETAILS ON SYMPTOMS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
281209 CLAREON PANOPTIX TRIFOCAL UV ABSORBING INTRAOCULAR LENS LENS, MULTIFOCAL INTRAOCULAR MFK ALCON RESEARCH, LLC - HUNTINGTON CCWTT0 16021898 00380652413664

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other